UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The eXpeRience registry: The ‘real-world’ effectiveness of omalizumab in allergic asthma

Respiratory medicine, 2013-08, Vol.107 (8), p.1141-1151

2013

Volltextzugriff (PDF)

Persistency of response to omalizumab therapy in severe allergic (IgE‐mediated) asthma

Allergy (Copenhagen), 2011-05, Vol.66 (5), p.671-678

2011

Volltextzugriff (PDF)

Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data

Respiratory medicine, 2010-09, Vol.104 (9), p.1381-1385

2010

Volltextzugriff (PDF)

WS01.2 TOBI® for eradication of early P. aeruginosa infection in paediatric cystic fibrosis patients: the EARLY study

Journal of cystic fibrosis, 2016-06, Vol.15, p.S1-S1

2016

Volltextzugriff (PDF)

Reductions In Oral Corticosteroid Use In Patients With Allergic (IgE- Mediated) Asthma Receiving Omalizumab

Journal of allergy and clinical immunology, 2012-02, Vol.129 (2), p.AB72-AB72

2012

Volltextzugriff (PDF)

72 Inspiratory flow characteristics of the T-326 dry powder inhaler (DPI) in CF patients

Journal of cystic fibrosis, 2013-06, Vol.12, p.S66-S66

2013

Volltextzugriff (PDF)

Adding Omalizumab to the Therapy of Adolescents With Persistent Uncontrolled Moderate—Severe Allergic Asthma

Clinical pediatrics, 2009-10, Vol.48 (8), p.859-865

2009

Volltextzugriff (PDF)

Effect of Omalizumab on Asthma Control and Quality of Life in Patients with Moderate-Severe Persistent IgE-Mediated Asthma and Allergy to House Dust Mite

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S157-S157

2008

Volltextzugriff (PDF)

Addition of Omalizumab Improved Functional Health Status in Patients With Impaired Quality of Life Associated With Moderate-Severe Persistent Allergic Asthma

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S154-S154

2008

Volltextzugriff (PDF)

Clinically Relevant Improvements in Asthma-Related Quality of Life in Patients Receiving Omalizumab as Add-On Therapy

Journal of allergy and clinical immunology, 2006-02, Vol.117 (2), p.S8-S8

2006

Volltextzugriff (PDF)

Treatment of Chronic Autoimmune Urticaria with Omalizumab

Journal of allergy and clinical immunology, 2008-02, Vol.121 (2), p.S226-S227

2008

Volltextzugriff (PDF)

In Moderate-Severe Asthma, Omalizumab Reduced the Need for Rescue Systemic Steroid Bursts and Improved Ratings of Treatment Effectiveness: A Pooled Analysis

Journal of allergy and clinical immunology, 2006-02, Vol.117 (2), p.S10-S10

2006

Volltextzugriff (PDF)

Das eXpeRience Register: Beobachtung der tatsächlichen Wirkung von Omalizumab bei allergischem Asthma

Pneumologie (Stuttgart, Germany), 2012, Vol.66 (S 01)

2012

Volltextzugriff (PDF)

Prädiktor für den Behandlungserfolg mit Omalizumab (XOLAIR®, OMA) bei Patienten mit schwerem allergischem (IgE-vermitteltem) Asthma

Pneumologie (Stuttgart, Germany), 2010, Vol.64 (S 03)

2010

Volltextzugriff (PDF)

Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma: Persistency of response to omalizumab

Allergy (Copenhagen), 2011-05, Vol.66 (5), p.671-678

2011

Volltextzugriff (PDF)

Implementation of guidelines for preoperative laboratory investigations in patients scheduled to undergo elective surgery

Canadian Journal of Surgery, 1994-10, Vol.37 (5), p.397-401

1994

Volltextzugriff (PDF)

Pathophysiology and implications for treatment of acute respiratory distress syndrome

AACN clinical issues, 2000-05, Vol.11 (2), p.179-197

2000

Volltextzugriff (PDF)

Omalizumab Reduced Need for Steroid Bursts in Asthmatics Concomitantly Using Leukotrine Receptor Antagonists (LTRAs)

Journal of allergy and clinical immunology, 2006-02, Vol.117 (2), p.S280-S280

2006

Volltextzugriff (PDF)

Omalizumab Reduced Need for Steroid Bursts and Improved Treatment Effectiveness in Asthmatics on Inhaled Salmeterol and Fluticasone Combination Therapy

Journal of allergy and clinical immunology, 2006-02, Vol.117 (2), p.S10-S10

2006

Volltextzugriff (PDF)

PRS31 IMPACT OF UNCONTROLLED PEDIATRIC ASTHMA ON CHILD AND CAREGIVER PRODUCTIVITY

Value in health, 2008, Vol.11 (3), p.A279-A279

2008

Volltextzugriff (PDF)

PR3 IMPACT OF UNCONTROLLED PEDIATRIC ASTHMA ON HEALTH-RELATED QUALITY OF LIFE (HRQOL)

Value in health, 2008, Vol.11 (3), p.A26-A26

2008

Volltextzugriff (PDF)

Two Year Follow-Up of Patients with Chronic Autoimmune Urticaria Treated with Omalizumab

Journal of allergy and clinical immunology, 2010-02, Vol.125 (2), p.AB67-AB67

2010

Volltextzugriff (PDF)

Effect of Omalizumab on Pulmonary Function and Asthma-related Outcome Measures in Patients Allergic to Cat Dander

Clinical immunology (Orlando, Fla.), 2007-01, Vol.123, p.S75-S75

2007

Volltextzugriff (PDF)

Addition of Omalizumab Reduces School Absenteeism in Children with Moderate-Severe Persistent Asthma

Journal of allergy and clinical immunology, 2007, Vol.119 (1), p.S150-S150

2007

Volltextzugriff (PDF)

Effect of Omalizumab on Measures of Control in Adolescents with Moderate-Severe Persistent Asthma

Journal of allergy and clinical immunology, 2007, Vol.119 (1), p.S10-S10

2007

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(39)
Tagungsberichte
(2)

Sprache

Englisch
(39)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The eXpeRience registry: The ‘real-world’ effectiveness of omalizumab in allergic asthma

Persistency of response to omalizumab therapy in severe allergic (IgE‐mediated) asthma

Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data

WS01.2 TOBI® for eradication of early P. aeruginosa infection in paediatric cystic fibrosis patients: the EARLY study

Reductions In Oral Corticosteroid Use In Patients With Allergic (IgE- Mediated) Asthma Receiving Omalizumab

72 Inspiratory flow characteristics of the T-326 dry powder inhaler (DPI) in CF patients

Adding Omalizumab to the Therapy of Adolescents With Persistent Uncontrolled Moderate—Severe Allergic Asthma

Effect of Omalizumab on Asthma Control and Quality of Life in Patients with Moderate-Severe Persistent IgE-Mediated Asthma and Allergy to House Dust Mite

Addition of Omalizumab Improved Functional Health Status in Patients With Impaired Quality of Life Associated With Moderate-Severe Persistent Allergic Asthma

Clinically Relevant Improvements in Asthma-Related Quality of Life in Patients Receiving Omalizumab as Add-On Therapy

Treatment of Chronic Autoimmune Urticaria with Omalizumab

In Moderate-Severe Asthma, Omalizumab Reduced the Need for Rescue Systemic Steroid Bursts and Improved Ratings of Treatment Effectiveness: A Pooled Analysis

Das eXpeRience Register: Beobachtung der tatsächlichen Wirkung von Omalizumab bei allergischem Asthma

Prädiktor für den Behandlungserfolg mit Omalizumab (XOLAIR®, OMA) bei Patienten mit schwerem allergischem (IgE-vermitteltem) Asthma

Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma: Persistency of response to omalizumab

Implementation of guidelines for preoperative laboratory investigations in patients scheduled to undergo elective surgery

Pathophysiology and implications for treatment of acute respiratory distress syndrome

Omalizumab Reduced Need for Steroid Bursts in Asthmatics Concomitantly Using Leukotrine Receptor Antagonists (LTRAs)

Omalizumab Reduced Need for Steroid Bursts and Improved Treatment Effectiveness in Asthmatics on Inhaled Salmeterol and Fluticasone Combination Therapy

PRS31 IMPACT OF UNCONTROLLED PEDIATRIC ASTHMA ON CHILD AND CAREGIVER PRODUCTIVITY

PR3 IMPACT OF UNCONTROLLED PEDIATRIC ASTHMA ON HEALTH-RELATED QUALITY OF LIFE (HRQOL)

Two Year Follow-Up of Patients with Chronic Autoimmune Urticaria Treated with Omalizumab

Effect of Omalizumab on Pulmonary Function and Asthma-related Outcome Measures in Patients Allergic to Cat Dander

Addition of Omalizumab Reduces School Absenteeism in Children with Moderate-Severe Persistent Asthma

Effect of Omalizumab on Measures of Control in Adolescents with Moderate-Severe Persistent Asthma

Suchergebnisse filtern